Objectives:
1. Review of complement pathways
2. Explore the evidence behind the role of complements in ANCA-associated vasculitis
3. Review Avacopan phase II trial
Session date:
02/27/2018 - 8:30am to 9:30am CST
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Iazsmin Ventura, M.D.